Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency

Diabetes Research and Clinical Practice

Volumn 97, Issue 3, 2012, Pages 359-367

  Mazokopakis, Elias E ^a   Starakis, Ioannis K ^b  

^a Naval Hospital of Crete   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Cobalamin; Deficiency; Folate; Homocysteine; Metformin; MMA; Vitamin B12

Indexed keywords

BIGUANIDE DERIVATIVE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; INSULIN; INTRINSIC FACTOR; METFORMIN; METHYLMALONIC ACID; MULTIVITAMIN; PARIETAL CELL ANTIBODY; PEPSINOGEN; POTASSIUM; TRANSCOBALAMIN;

BILIRUBIN BLOOD LEVEL; CLINICAL EXAMINATION; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; DIABETIC PATIENT; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ERYTHROPOIESIS; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GASTROSCOPY; HEMATOLOGIC DISEASE; HUMAN; HYPOKALEMIA; IRON BLOOD LEVEL; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MALABSORPTION; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MEGALOBLASTIC ANEMIA; MEGALOCYTOSIS; NERVE DEGENERATION; PERIPHERAL NEUROPATHY; PERNICIOUS ANEMIA; PREVALENCE; REVIEW; SCHILLING TEST; SIDE EFFECT;

HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MODELS, BIOLOGICAL; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; VITAMIN B 12 DEFICIENCY;

EID: 84866529337     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.06.001     Document Type: Review

References (66)

1. Witters L.A. The blooming of the French lilac. J Clin Invest 2001, 108:1105-1107.
2. Bouchoucha M., Uzzan B., Cohen R. Metformin and digestive disorders. Diabetes Metab 2011, 37:90-96.
3. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
4. American Diabetes Association, et al. Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(Suppl. 1):S11-S63.
5. Kirpichnikov D., McFarlane S.I., Sowers J.R. Metformin: an update. Ann Intern Med 2002, 137:25-33.
6. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007, 100:328-341.
7. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
8. Bailey C.J. Biguanides and NIDDM. Diabetes Care 1992, 15:755-772.
9. Collier C.A., Bruce C.R., Smith A.C., Lopaschuk G., Dyck D.J. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab 2006, 291:E182-E189.
10. Bailey C.J., Turner R.C. Metformin. N Engl J Med 1996, 334:574-579.
11. Cho Y.M., Kieffer T.J. New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser. Diabetologia 2011, 54:219-222.
12. Maida A., Lamont B.J., Cao X., Drucker D.J. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor alpha in mice. Diabetologia 2011, 54:339-349.
13. Yasuda N., Inoue T., Nagakura T., Yamazaki K., Kira K., Saeki T., et al. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. Biochem Biophys Res Commun 2002, 298:779-784.
14. Migoya E.M., Bergeron R., Miller J.L., Snyder R.N., Tanen M., Hilliard D., et al. Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther 2010, 88:801-808.
15. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352:854-865.
16. Kooy A., de Jager J., Lehert P., Bets D., Wulffele M.G., Donker A.J., et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med 2009, 169:616-625.
17. de Jager J., Kooy A., Lehert P., Wulffelé M.G., van der Kolk J., Bets D., et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ 2010, 340:c2181.
18. Sahin M., Tutuncu N.B., Ertugrul D., Tanaci N., Guvener N.D. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. J Diabetes Complicat 2007, 21:118-123.
19. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998, 338:1042-1050.
20. Wile D.J., Toth C. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care 2010, 33:156-161.
21. Berchtold P., Bolli P., Arbenz U., Keiser G. Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides) [Article in German]. Diabetologia 1969, 5:405-412.
22. Callaghan T.S., Hadden D.R., Tomkin G.H. Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment. Br Med J 1980, 280:1214-1215.
23. Tomkin G.H., Hadden D.R., Weaver J.A., Montgomery D.A. Vitamin-B12 status of patients on long-term metformin therapy. Br Med J 1971, 2:685-687.
24. Adams J.F., Clark J.S., Ireland J.T., Kesson C.M., Watson W.S. Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia 1983, 24:16-18.
25. Bauman W.A., Shaw S., Jayatilleke E., Spungen A.M., Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000, 23:1227-1231.
26. Wulffele M.G., Kooy A., Lehert P., Bets D., Ogterop J.C., Borger Van Der Burg B., et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2003, 254:455-463.
27. Hermann L.S., Nilsson B.O., Wettre S. Vitamin B12 status of patients treated with metformin: a cross-sectional cohort study. Br J Diabetes Vasc Dis 2004, 4:401-406.
28. Ting R.Z., Szeto C.C., Chan M.H., Ma K.K., Chow K.M. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med 2006, 166:1975-1979.
29. Pflipsen M.C., Oh R.C., Saguil A., Seehusen D.A., Seaquist D., Topolski R. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med 2009, 22:528-534.
30. Nervo M., Lubini A., Raimundo F.V., Faulhaber G.A., Leite C., Fischer L.M., et al. Vitamin B12 in metformin-treated diabetic patients: a cross-sectional study in Brazil. Rev Assoc Med Bras 2011, 57:46-49.
31. Reinstatler L., Qi Y.P., Williamson R.S., Garn J.V., Oakley G.P. Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2012, 35:327-333.
32. Gilligan M.A. Metformin and vitamin B12 deficiency. Arch Intern Med 2002, 162:484-485.
33. Andrès E., Noel E., Goichot B. Metformin-associated vitamin B12 deficiency. Arch Intern Med 2002, 162:2251-2252.
34. Filioussi K., Bonovas S., Katsaros T. Should we screen diabetic patients using biguanides for megaloblastic anaemia. Aust Fam Physician 2003, 32:383-384.
35. Liu K.W., Dai L.K., Jean W. Metformin-related vitamin B12 deficiency. Age Ageing 2006, 35:200-201.
36. Bell D.S. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010, 103:265-267.
37. DeFronzo R.A., Goodman A.M. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995, 333:541-549.
38. Hoffbrand V., Provan D. ABC of clinical haematology. Macrocytic anaemias. BMJ 1997, 314:430-433.
39. Snow C.F. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med 1999, 159:1289-1298.
40. 12 deficiency: is it necessary?. Pract Diabetes 2011, 28:302-304.
41. Jensen R.T. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol 2006, 98:4-19.
42. Ruscin J.M., Page R.L., Valuck R.J. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother 2002, 36:812-816.
43. Bell D.S. Nondiabetic neuropathy in a patient with diabetes. Endocr Pract 1995, 1:393-394.
44. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008, 112:2214-2221.
45. Antony A.C. Megaloblastic anemias. Hematology: basic principles and practice 2005, 519. Churchill Livingstone, New York. 4th ed. R. Hoffman, E.J. Benz, S.J. Shattil (Eds.).
46. Matchar D.B., McCrory D.C., Millington D.S., Feussner J.R. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci 1994, 308:276-283.
47. Moore E., Mander A., Ames D., Carne R., Sanders K., Watters D. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012, 24:541-556.
48. Naurath H.J., Joosten E., Riezler R., Stabler S.P., Allen R.H., Lindenbaum J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995, 346:85-89.
49. Lindenbaum J., Savage D.G., Stabler S.P., Allen R.H. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990, 34:99-107.
50. Tefferi A., Pruthi R.K. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994, 69:181-186.
51. Rosenson RS, Kang DS. Overview of homocysteine. Available on 2012 UpToDate, Inc.
52. Savage D.G., Lindenbaum J., Stabler S.P., Allen R.H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994, 96:239-246.
53. Schrier SL. Diagnosis and treatment of vitamin B12 and folic acid deficiency. Available on 2012 UpToDate, Inc.
54. Hvas A.M., Nexo E. Diagnosis and treatment of vitamin B12 deficiency. An update. Haematologica 2006, 91:1506-1512.
55. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000, 51:357-375.
56. Andres E., Serraj K., Mecili M., Kaltenbach G., Vogel T. The syndrome of food-cobalamin malabsorption: a personal view in a perspective of clinical practice. J Blood Disord Transfus 2011, 2:108.
57. Mazokopakis E.E., Karefilakis C.M., Giannopoulou C. Is Schilling test necessary for the etiological diagnosis of B12 insufficiency. Hell J Nucl Med 2009, 12:84-86.
58. Andrès E., Loukili N.H., Noel E., Kaltenbach G., Abdelgheni M.B., Perrin A.E., et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004, 171:251-259.
59. Oh R., Brown D.L. Use of metformin is a cause of vitamin B12 deficiency. Am Fam Physician 2004, 69:264. [author reply 264, 266].
60. Gargari B.P., Aghamohammadi V., Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract 2011, 94:33-38.
61. Mohammadi M., Amini M., Aminiorroay A., Rezvanian H., Kachuei A., Siyavash M., et al. Effect of metformin and folic acid on plasma homocysteine level in type 2 diabetic patients. Int J Med Sci 2009, 1:88-90.
62. Hultdin J., Van Guelpen B., Bergh A., Hallmans G., Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 2005, 113:819-824.
63. Stevens V.L., Rodriguez C., Pavluck A.L., McCullough M.L., Thun M.J., Calle E.E. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006, 163:989-996.
64. Buvat D.R. Use of metformin is a cause of vitamin B12 deficiency. Am Fam Physician 2004, 69:264.
65. Stowers J.M., Smith O.A. Vitamin B12 and metformin. Br Med J 1971, 3:246-247.
66. Mahajan R., Gupta K. Revisiting metformin: annual vitamin B12 supplementation may become mandatory with long-term metformin use. J Young Pharm 2010, 2:428-429.